Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Different Strategies for Formation of PEGylated EGF-Conjugated PEI/DNA Complexes for Targeted Gene Delivery

Identifieur interne : 002276 ( Main/Exploration ); précédent : 002275; suivant : 002277

Different Strategies for Formation of PEGylated EGF-Conjugated PEI/DNA Complexes for Targeted Gene Delivery

Auteurs : Thomas Blessing [Autriche, France] ; Malgorzata Kursa [Autriche] ; Robert Holzhauser [Autriche] ; Ralf Kircheis [Autriche] ; Ernst Wagner [Autriche, Allemagne]

Source :

RBID : ISTEX:5BDA273D2BD7C85D0528CE1426C5CDE263EF638C

Abstract

With the aim of generating gene delivery systems for tumor targeting, we have synthesized a conjugate consisting of polyethylenimine (PEI) covalently modified with epidermal growth factor (EGF) peptides. Transfection efficiency of the conjugate was evaluated and compared to native PEI in three tumor cell lines:  KB epidermoid carcinoma cells, CMT-93 rectum carcinoma cells, and Renca-EGFR renal carcinoma cells. Depending on the tumor cell line, incorporation of EGF resulted in an up to 300-fold increased transfection efficiency. This ligand-mediated enhancement and competition with free EGF strongly suggested uptake of the complexes through the EGF receptor-mediated endocytosis pathway. Shielded particles being crucial for systemic gene delivery, we studied the effect of covalent surface modification of EGF−PEI/DNA complexes with a poly(ethylene glycol) (PEG) derivative. An alternative way for the formation of PEGylated EGF-containing complexes was also evaluated where EGF was projected away from PEI/DNA core complexes through a PEG linker. Both strategies led to shielded particles still able to efficiently transfect tumor cells in a receptor-dependent fashion. These PEGylated EGF-containing complexes were 10- to 100-fold more efficient than PEGylated complexes without EGF.

Url:
DOI: 10.1021/bc0001488


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Different Strategies for Formation of PEGylated EGF-Conjugated PEI/DNA Complexes for Targeted Gene Delivery</title>
<author>
<name sortKey="Blessing, Thomas" sort="Blessing, Thomas" uniqKey="Blessing T" first="Thomas" last="Blessing">Thomas Blessing</name>
</author>
<author>
<name sortKey="Kursa, Malgorzata" sort="Kursa, Malgorzata" uniqKey="Kursa M" first="Malgorzata" last="Kursa">Malgorzata Kursa</name>
</author>
<author>
<name sortKey="Holzhauser, Robert" sort="Holzhauser, Robert" uniqKey="Holzhauser R" first="Robert" last="Holzhauser">Robert Holzhauser</name>
</author>
<author>
<name sortKey="Kircheis, Ralf" sort="Kircheis, Ralf" uniqKey="Kircheis R" first="Ralf" last="Kircheis">Ralf Kircheis</name>
</author>
<author>
<name sortKey="Wagner, Ernst" sort="Wagner, Ernst" uniqKey="Wagner E" first="Ernst" last="Wagner">Ernst Wagner</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5BDA273D2BD7C85D0528CE1426C5CDE263EF638C</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1021/bc0001488</idno>
<idno type="url">https://api.istex.fr/ark:/67375/TPS-J0F4G1J1-8/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000928</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000928</idno>
<idno type="wicri:Area/Istex/Curation">000928</idno>
<idno type="wicri:Area/Istex/Checkpoint">001099</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001099</idno>
<idno type="wicri:doubleKey">1043-1802:2001:Blessing T:different:strategies:for</idno>
<idno type="wicri:Area/Main/Merge">002300</idno>
<idno type="wicri:Area/Main/Curation">002276</idno>
<idno type="wicri:Area/Main/Exploration">002276</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Different Strategies for Formation of PEGylated EGF-Conjugated PEI/DNA Complexes for Targeted Gene Delivery</title>
<author>
<name sortKey="Blessing, Thomas" sort="Blessing, Thomas" uniqKey="Blessing T" first="Thomas" last="Blessing">Thomas Blessing</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Institute of Medical Biochemistry, University of Vienna, Dr. Bohrgasse 9/3, A-1030 Vienna and BoehringerIngelheim Austria, Dr. Boehringer Gasse 5-11, A-1121 Vienna</wicri:regionArea>
<wicri:noRegion>A-1121 Vienna</wicri:noRegion>
</affiliation>
<affiliation wicri:level="0">
<country wicri:rule="zip">France</country>
</affiliation>
</author>
<author>
<name sortKey="Kursa, Malgorzata" sort="Kursa, Malgorzata" uniqKey="Kursa M" first="Malgorzata" last="Kursa">Malgorzata Kursa</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Institute of Medical Biochemistry, University of Vienna, Dr. Bohrgasse 9/3, A-1030 Vienna and BoehringerIngelheim Austria, Dr. Boehringer Gasse 5-11, A-1121 Vienna</wicri:regionArea>
<wicri:noRegion>A-1121 Vienna</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Holzhauser, Robert" sort="Holzhauser, Robert" uniqKey="Holzhauser R" first="Robert" last="Holzhauser">Robert Holzhauser</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Institute of Medical Biochemistry, University of Vienna, Dr. Bohrgasse 9/3, A-1030 Vienna and BoehringerIngelheim Austria, Dr. Boehringer Gasse 5-11, A-1121 Vienna</wicri:regionArea>
<wicri:noRegion>A-1121 Vienna</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kircheis, Ralf" sort="Kircheis, Ralf" uniqKey="Kircheis R" first="Ralf" last="Kircheis">Ralf Kircheis</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Institute of Medical Biochemistry, University of Vienna, Dr. Bohrgasse 9/3, A-1030 Vienna and BoehringerIngelheim Austria, Dr. Boehringer Gasse 5-11, A-1121 Vienna</wicri:regionArea>
<wicri:noRegion>A-1121 Vienna</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Wagner, Ernst" sort="Wagner, Ernst" uniqKey="Wagner E" first="Ernst" last="Wagner">Ernst Wagner</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Institute of Medical Biochemistry, University of Vienna, Dr. Bohrgasse 9/3, A-1030 Vienna and BoehringerIngelheim Austria, Dr. Boehringer Gasse 5-11, A-1121 Vienna</wicri:regionArea>
<wicri:noRegion>A-1121 Vienna</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea> New address:  Department of Pharmacy, Ludwig-Maximilians-University, Butenandtstr 5-13, D-81377 Munich</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
<orgName type="university">Université Louis-et-Maximilien de Munich</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Bioconjugate Chemistry</title>
<title level="j" type="abbrev">Bioconjugate Chem.</title>
<idno type="ISSN">1043-1802</idno>
<idno type="eISSN">1520-4812</idno>
<imprint>
<publisher>American Chemical Society</publisher>
<date type="e-published" when="2001-06-23">2001</date>
<date when="2001-07-18">2001</date>
<biblScope unit="vol">12</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="529">529</biblScope>
<biblScope unit="page" to="537">537</biblScope>
</imprint>
<idno type="ISSN">1043-1802</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1043-1802</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">With the aim of generating gene delivery systems for tumor targeting, we have synthesized a conjugate consisting of polyethylenimine (PEI) covalently modified with epidermal growth factor (EGF) peptides. Transfection efficiency of the conjugate was evaluated and compared to native PEI in three tumor cell lines:  KB epidermoid carcinoma cells, CMT-93 rectum carcinoma cells, and Renca-EGFR renal carcinoma cells. Depending on the tumor cell line, incorporation of EGF resulted in an up to 300-fold increased transfection efficiency. This ligand-mediated enhancement and competition with free EGF strongly suggested uptake of the complexes through the EGF receptor-mediated endocytosis pathway. Shielded particles being crucial for systemic gene delivery, we studied the effect of covalent surface modification of EGF−PEI/DNA complexes with a poly(ethylene glycol) (PEG) derivative. An alternative way for the formation of PEGylated EGF-containing complexes was also evaluated where EGF was projected away from PEI/DNA core complexes through a PEG linker. Both strategies led to shielded particles still able to efficiently transfect tumor cells in a receptor-dependent fashion. These PEGylated EGF-containing complexes were 10- to 100-fold more efficient than PEGylated complexes without EGF.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
<li>Autriche</li>
<li>France</li>
</country>
<region>
<li>Bavière</li>
<li>District de Haute-Bavière</li>
</region>
<settlement>
<li>Munich</li>
</settlement>
<orgName>
<li>Université Louis-et-Maximilien de Munich</li>
</orgName>
</list>
<tree>
<country name="Autriche">
<noRegion>
<name sortKey="Blessing, Thomas" sort="Blessing, Thomas" uniqKey="Blessing T" first="Thomas" last="Blessing">Thomas Blessing</name>
</noRegion>
<name sortKey="Holzhauser, Robert" sort="Holzhauser, Robert" uniqKey="Holzhauser R" first="Robert" last="Holzhauser">Robert Holzhauser</name>
<name sortKey="Kircheis, Ralf" sort="Kircheis, Ralf" uniqKey="Kircheis R" first="Ralf" last="Kircheis">Ralf Kircheis</name>
<name sortKey="Kursa, Malgorzata" sort="Kursa, Malgorzata" uniqKey="Kursa M" first="Malgorzata" last="Kursa">Malgorzata Kursa</name>
<name sortKey="Wagner, Ernst" sort="Wagner, Ernst" uniqKey="Wagner E" first="Ernst" last="Wagner">Ernst Wagner</name>
</country>
<country name="France">
<noRegion>
<name sortKey="Blessing, Thomas" sort="Blessing, Thomas" uniqKey="Blessing T" first="Thomas" last="Blessing">Thomas Blessing</name>
</noRegion>
</country>
<country name="Allemagne">
<region name="Bavière">
<name sortKey="Wagner, Ernst" sort="Wagner, Ernst" uniqKey="Wagner E" first="Ernst" last="Wagner">Ernst Wagner</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002276 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002276 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:5BDA273D2BD7C85D0528CE1426C5CDE263EF638C
   |texte=   Different Strategies for Formation of PEGylated EGF-Conjugated PEI/DNA Complexes for Targeted Gene Delivery
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021